Search

Pages

1. • Journal article

   • 

   [Clinical-pharmacology of Lipid Lowering Drugs]

   Harvengt, C. Heller, F. Desager, Jean-Pierre[UCL] (1983) Pathologie et Biologie — Vol. 31, no. 4, p. 284-296 (1983)
2. • Journal article

   • 

   Pharmacodynamic activity of lipoprotein lipase and hepatic lipase, and pharmacokinetic parameters measured in normolipidaemic subjects receiving ciprofibrate (100 or 200 mg/day) or micronised fenofibrate (200 mg/day) therapy for 23 days.

   Desager, Jean-Pierre[UCL] Horsmans, Yves[UCL] Vandenplas, C Harvengt, C.[UCL] (1996) Atherosclerosis — Vol. 124 Suppl, p. S65-73 (1996)
3. • Journal article

   • 

   [Inhibition By Ranitidin of the Gastric-secretion in Patients of An Intensive-care Unit]

   Reynaert, M. Macchi, H. Fiasse, René[UCL] Desager, Jean-Pierre[UCL] Dive, Charles[UCL] (1982) Acta Gastro-Enterologica Belgica (Multilingual Edition) — Vol. 45, no. 5-6, p. 251-252 (1982)
4. • Journal article

   • 

   Hypolipidemic and Hypouricemic Action of Fenofibrate in Various Types of Hyperlipoproteinemias

   Harvengt, C. Heller, F. Desager, Jean-Pierre[UCL] (1980) Artery : an international journal for rapid communication of arterial research — Vol. 7, no. 1, p. 73-82 (1980)
5. • Journal article

   • 

   [Sensibility and Specificity of Urinary Catecholamines and Their Acidic Metabolites for Neuroblastomas Diagnosis in Children]

   Horsmans, Yves[UCL] Desager, Jean-Pierre[UCL] Harvengt, C. (1990) Bulletin du Cancer — Vol. 77, no. 10, p. 985-989 (1990)
6. • Journal article

   • 

   Pharmacokinetic Consequences of Long-term Coadministration of Cimetidine and Triazolobenzodiazepines, Alprazolam and Triazolam, in Healthy-subjects

   Pourbaix, S. Desager, Jean-Pierre[UCL] Hulhoven, R. Smith, RB. Harvengt, C. (1985) International Journal of Clinical Pharmacology and Therapeutics — Vol. 23, no. 8, p. 447-451 (1985)
7. • Journal article

   • 

   Plasma-lipid Concentrations and Lecithin - Cholesterol Acyltransferase Activity in Normolipidemic Subjects Given Fenofibrate and Colestipol

   Heller, F. Desager, Jean-Pierre[UCL] Harvengt, C. (1981) Acta Cardiologica : an international journal of cardiology — , p. 103-106 (1981)
8. • Journal article

   • 

   C-14-propoxyphene demethylation in the rat - An example of differences between liver and intestinal drug-presystemic metabolism

   Horsmans, Yves[UCL] Pauwels, Stanislas[UCL] Saliez, Alain[UCL] VandenBerge, V Desager, Jean-Pierre[UCL] Geubel, André[UCL] Lambotte, Luc[UCL] (1997) Drug Metabolism and Disposition : the biological fate of chemicals — Vol. 25, no. 11, p. 1257-1259 (1997)
9. • Journal article

   • 

   Effects On Plasma Apoproteins-ai and Apoprotein-b Induced By 2 Estro-progestin Preparations - Monophasic Versus Triphasic

   Harvengt, C. Desager, Jean-Pierre[UCL] Lecart, Claude[UCL] (1983) Current Therapeutic Research : clinical and experimental — Vol. 33, no. 3, p. 385-393 (1983)
10. • Speech

    • 

    Is the dosage of red blood cell 6-thioguanine concentration (RBC 6-TGN) useful in the management of Crohn's disease (Cd) treated with azathioprine (AZA) and 6-mercaptopurine (6-MP)?

    Belaiche, J Horsmans, Yves[UCL] Desager, Jean-Pierre[UCL] Louis, E (2000) —
11. • Journal article

    • 

    Kinetics of a Single Dose Combination of Nifedipine Acebutolol in Patients With Chronic Liver-disease

    Lejeune, P. Desager, Jean-Pierre[UCL] Meunier, H. Harvengt, C. (1988) International Journal of Clinical Pharmacology and Therapeutics — Vol. 26, no. 10, p. 513-516 (1988)
12. • Journal article

    • 

    Plasma-lipid Concentrations and Lecithin - Cholesterol Acyltransferase Activity in Normolipidemic Subjects Given Fenofibrate and Colestipol

    Heller, FR. Desager, Jean-Pierre[UCL] Harvengt, C. (1981) Metabolism : clinical and experimental — Vol. 30, no. 1, p. 67-71 (1981)
13. • Journal article

    • 

    Bioavailability of (-)-moprolol in the Dog

    Marzo, A. Desager, Jean-Pierre[UCL] (1981) Current Therapeutic Research : clinical and experimental — Vol. 30, no. 4, p. 442-446 (1981)
14. • Journal article

    • 

    A pharmacokinetic evaluation of the second-generation H1-receptor antagonist cetirizine in very young children.

    Desager, Jean-Pierre[UCL] Dab, I. Horsmans, Yves[UCL] Harvengt, C. (1993) Clinical pharmacology and therapeutics — Vol. 53, no. 4, p. 431-5 (1993)
15. • Journal article

    • 

    Sensitive assay for midazolam and its metabolite 1'-hydroxymidazolam in human plasma by capillary high-performance liquid chromatography.

    Eeckhoudt, S L Desager, Jean-Pierre[UCL] Horsmans, Yves[UCL] De Winne, A J Verbeeck, Roger-K.[UCL] (1998) Journal of chromatography. B, Biomedical sciences and applications — Vol. 710, no. 1-2, p. 165-71 (1998)
16. • Journal article

    • 

    Reduction in hepatic cytochrome P-450 is correlated to the degree of liver fat content in animal models of steatosis in the absence of inflammation.

    Leclercq, Isabelle[UCL] Horsmans, Yves[UCL] Desager, Jean-Pierre[UCL] Delzenne, Nathalie M.[UCL] Geubel, André[UCL] (1998) Journal of hepatology — Vol. 28, no. 3, p. 410-6 (1998)
17. • Journal article

    • 

    Estimation of chlorzoxazone hydroxylase activity in liver microsomes and of the plasma pharmacokinetics of chlorzoxazone by the same high-performance liquid chromatographic method.

    Leclercq, Isabelle[UCL] Horsmans, Yves[UCL] Desager, Jean-Pierre[UCL] (1998) Journal of chromatography. A — Vol. 828, no. 1-2, p. 291-6 (1998)
18. • Speech

    • 

    Reduction in CYP activities is correlated to the degree of fat liver content in two animal models of nutritional steatosis.

    Leclercq, Isabelle[UCL] Horsmans, Yves[UCL] Desager, Jean-Pierre[UCL] Delzenne, Nathalie M.[UCL] Geubel, André[UCL] (1996) —
19. • Speech

    • 

    Influence of diet on liver volume and cytochrome P-450 (CYP) activities in human non-alcoholic fatty liver.

    Leclercq, Isabelle[UCL] Horsmans, Yves[UCL] Pauwels, Stanislas[UCL] Desager, Jean-Pierre[UCL] Geubel, André[UCL] (1996) —
20. • Journal article

    • 

    Fast determination of low-level cytochrome P-450 1A1 activity by high-performance liquid chromatography with fluorescence or visible absorbance detection.

    Leclercq, Isabelle[UCL] Desager, Jean-Pierre[UCL] Vandenplas, C. Horsmans, Yves[UCL] (1996) Journal of Chromatography. B, Biomedical Applications — Vol. 681, no. 2, p. 227-232 (1996)
21. • Journal article

    • 

    Inhibition of chlorzoxazone metabolism, a clinical probe for CYP2E1, by a single ingestion of watercress

    Leclercq, Isabelle[UCL] Horsmans, Yves[UCL] Desager, Jean-Pierre[UCL] (1998) Clinical Pharmacology and Therapeutics — Vol. 64, no. 2, p. 144-149 (1998)
22. • Journal article

    • 

    Prevalence of drug hydroxylator phenotypes in Belgium.

    Leclercq, V.[UCL] Desager, Jean-Pierre[UCL] van Nieuwenhuyze, Y Harvengt, C. (1987) European journal of clinical pharmacology — Vol. 33, no. 4, p. 439-40 (1987)
23. • Journal article

    • 

    Plasma Enoximone Concentrations in Cardiac Patients

    Desager, Jean-Pierre[UCL] Installé, Etienne[UCL] Harvengt, C. (1990) Current Therapeutic Research : clinical and experimental — Vol. 47, no. 4, p. 743-752 (1990)
24. • Journal article

    • 

    Clinical pharmacokinetics of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors.

    Desager, Jean-Pierre[UCL] Horsmans, Yves[UCL] (1996) Clinical pharmacokinetics — Vol. 31, no. 5, p. 348-71 (1996)
25. • Journal article

    • 

    Possible interactions between zolpidem, a new sleep inducer and chlorpromazine, a phenothiazine neuroleptic.

    Desager, Jean-Pierre[UCL] Hulhoven, R. Harvengt, C. Hermann, P Guillet, Pierre[UCL] Thiercelin, J F (1988) Psychopharmacology — Vol. 96, no. 1, p. 63-6 (1988)

Pages